Video
Understanding the Impact of Parents’ Vaccine Hesitancy for Children As We Head Into Fall
Jay Lieberman, MD, a pediatric infectious disease specialist and the senior medical director of PRA Health Sciences, discusses his decision to enroll his twin daughters in the Moderna COVID-19 vaccine trial.
Pharmacy Times interviewed Jay Lieberman, MD, a pediatric infectious disease specialist and the senior medical director of PRA Health Sciences, on the future of COVID-19 disease and vaccines for adolescents and children.
Lieberman was a speaker at the World Vaccine Congress in a session on COVID-19 disease and vaccines for adolescents and children, specifically in light of his unique perspective on the subject due to having enrolled his twin daughters in the Moderna COVID-19 vaccine trial.
During the interview, Lieberman discusses why he decided to enroll his twin daughters in the Moderna COVID-19 vaccine trial, whether he had concerns about their enrollment in the trial, and what the potential ramifications could be if a significant number of parents remain uncomfortable with having their children vaccinated against COVID-19 as we head into the fall.
Chenodiol, First Treatment for Cerebrotendinous Xanthomatosis, Receives FDA Approval
